Skip to main content

Animations

MJFF Publications

4141 - 4150 of 9134 Results
Title
Year
  • Year
  • 2017
  • 2021
  • 2024
  • 2026
  • 2025
  • 2025
  • 2017
  • 2023
  • 2023
  • 2015
  • Summary Details
    OPEN
    Title: Reversible Conformational Conversion of α-Synuclein into Toxic Assemblies by Glucosylceramide
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuron.2017.12.012
    Citation Count: 228
  • Summary Details
    OPEN
    Title: Deep mining of oxysterols and cholestenoic acids in human plasma and cerebrospinal fluid: Quantification using isotope dilution mass spectrometry
    Journal Name: Analytica Chimica Acta
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.aca.2021.338259
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Mitochondrial import stress and PINK1-mediated mitophagy: the role of the PINK1-TOMM-TIMM23 supercomplex
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/15548627.2024.2340399
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Discordance of Dopaminergic Dysfunction and Subcortical Atrophy by α‐Synuclein Status in Sporadic and Genetic Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.70186
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Locus coeruleus degeneration is associated with orthostatic hypotension in Parkinson’s disease and multiple system atrophy
    Journal Name: Clinical Autonomic Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s10286-025-01164-2
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Type 2 Diabetes Mellitus, Cognitive Performance, and Incident Dementia; Identifying Mediating Pathways and Biomarkers From the Plasma Proteome
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/jnc.70306
    Citation Count: 3
  • The Kinase Fyn As a Novel Intermediate in l-DOPA-Induced Dyskinesia in Parkinson’s Disease
    2017
    Summary Details
    OPEN
    Title: The Kinase Fyn As a Novel Intermediate in l-DOPA-Induced Dyskinesia in Parkinson’s Disease
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s12035-017-0748-3
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Unanswered Questions in Clinical Practice
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13837
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Status of Current Biofluid Biomarkers in Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13753
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26248
    Citation Count: 100
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.